BEIJING, Oct. 18, 2021 /PRNewswire/ -- Concord Medical
Services Holdings Limited ("Concord Medical" or the "Company")
(NYSE: CCM), a healthcare provider specializing in cancer care,
research and prevention by operating a network of medically
advanced comprehensive cancer hospitals and standalone radiotherapy
and diagnostic imaging centers in China, today announced that two projects of
it, Jiahe Cloud Imaging Remote Medical Information Diagnosis
Platform ("Jiahe Cloud") and Jiahe
Feiyun Intelligent Radiotherapy Cloud Service Platform ("Jiahe
Feiyun"), were successfully shortlisted by the "5G+Healthcare"
pilot project, which is launched by Ministry of Industry and
Information Technology.
Jiahe Cloud provides digitized
solutions, with remote diagnosis as the core service, for medical
institutions. The platform consists of six modules: reginal imaging
remote diagnosis, bilateral referral, remote clinical consultation,
remote training, cloud filming and report, and remote ECG/
pathology/ ultrasound diagnosis.
Jiahe Feiyun is one of the six shortlisted radiotherapy projects
of the "5G+Healthcare" pilot project. It is a comprehensive service
platform that provides a variety of services including radiotherapy
process management, target area delineation, clinical cooperation
among doctors, remote quality control, multidisciplinary treatment,
remote training, big data analysis, etc.
About Concord Medical
Concord Medical Services Holdings Limited is a healthcare
provider specialized in cancer treatment, research, education and
prevention. The Company operates a network of medically advanced
comprehensive cancer hospitals and standalone radiotherapy and
diagnostic imaging centres in China. The Company focuses on providing
multidisciplinary cancer care approach in all areas of oncology
services in its cancer hospitals. The Company also equips its
hospitals with technologically advanced equipment such as the
state-of-the-art proton therapy system in its premium cancer
hospitals in top-tier cities including Beijing, Shanghai, and Guangzhou. In addition, the Company saw the
opportunity of the expanding market of medical equipment in
China and developed its product
life-cycle management services form its existing medical equipment
and consumable sales services. As of December 31, 2020, the
Company operated a network of 27 radiotherapy centers and
diagnostic imaging centers, which are based in 20 hospitals,
established under long-term lease and management services
arrangements with the Company and spanning over 20 cities across 13
provinces and administrative regions in China. To ensure the
commitment to the highest standard of medical services for
patients, the Company offers ongoing education and training for
doctors and other medical professionals in its network hospitals
and centres in both domestic and overseas medical institutions.
Safe Harbor Statement
This announcement contains forward-looking statements. These
forward-looking statements can be identified by words or phrases
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar expressions.
Forward-looking statements are inherently subject to uncertainties
and contingencies beyond the Company's control and based upon
premises with respect to future business decisions, which are
subject to change. A number of important factors could cause actual
results to differ materially from those contained in any
forward-looking statement. The Company does not undertake any
obligation to update any forward-looking statement, except as
required under applicable law.
see http://ir.ccm.cn.
View original
content:https://www.prnewswire.com/news-releases/concord-medical-is-shortlisted-for-the-5ghealthcare-pilot-project-301402023.html
SOURCE Concord Medical Services Holdings Limited